CSL (OTCMKTS:CSLLY) Trading Down 0.2% - Time to Sell?

Key Points

• Shares of CSL Limited (OTCMKTS:CSLLY) fell by 0.2%, closing at $87.04 after trading as low as $86.82.
• Approximately 66,125 shares were traded, which is a 31% increase from the average daily trading volume of 50,391 shares.
• CSL Limited operates in the biopharmaceutical sector, with key segments including CSL Behring and CSL Seqirus, focusing on plasma products and vaccines.

CSL Limited Sponsored ADR (OTCMKTS:CSLLY - Get Free Report)'s share price dropped 0.2% on Thursday . The stock traded as low as $86.82 and last traded at $87.04. Approximately 66,125 shares were traded during mid-day trading, an increase of 31% from the average daily volume of 50,391 shares. The stock had previously closed at $87.21.

CSL Stock Down 2.2%

The company has a quick ratio of 0.85, a current ratio of 1.86 and a debt-to-equity ratio of 0.45. The company's fifty day moving average price is $81.07 and its two-hundred day moving average price is $80.60.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.